Black widow spider (Latrodectus mactans) envenomation causes the clinical syndrome latrodectism, characterized by excess acetylcholine release leading to painful muscle rigidity, diaphoresis, and autonomic disturbances. [1-2] It is the most medically significant spider envenomation in the United States, prompting >2,500 poison center calls annually, though it is rarely life-threatening. [3-4]
1. History
- Bite circumstances: Ask about outdoor activity in shady, enclosed spaces — sheds, woodpiles, yard debris, gardening equipment, outdoor toilets, rock piles [1][5]
- Spider identification: Shiny black body with ventral red hourglass marking; however, markings may be absent or atypical (e.g., L. hesperus) [2-3]
- Symptom onset and progression: Initial bite may feel like a pinprick; pain is gradual in onset and migrates proximally from the bite site over minutes to hours [2]
- Pain characterization: Crampy, spasmodic pain — most commonly generalized abdominal, back, and leg pain [2][6]
- Associated symptoms: Diaphoresis (often in unusual patterns — localized to bite site, bilateral below-knee, or asymmetric regional), nausea, vomiting, headache, restlessness, chest tightness [1-2]
- Symptom pattern: Symptoms typically come in waves and continue for 48–72 hours [1]
- Pediatric presentation: Inconsolable crying, generalized erythema, excessive drooling [1]
2. Alarm Features
- Grade 3 envenomation: Generalized muscular pain (back, abdomen, chest), diaphoresis remote from bite site, abnormal vital signs (hypertension, tachycardia) [1]
- Severe abdominal rigidity mimicking acute surgical abdomen/peritonitis [1][5]
- Chest pain mimicking myocardial infarction [1][7]
- Respiratory distress — particularly in children and elderly [8]
- Cardiac involvement: Myocarditis, pulmonary edema, arrhythmias, Takotsubo-like cardiomyopathy (increasingly recognized, especially with European species; deaths mainly due to cardiogenic complications) [7-9]
- Rhabdomyolysis — rare but reported [5][9]
- Latrodectus facies: Periorbital edema, lacrimation, blepharospasm — distinctive but uncommon finding, especially in children [3]
3. Medications
- First-line analgesia: NSAIDs and acetaminophen for mild (Grade 1) envenomation [1-2]
- Opioids: Parenteral morphine for moderate-severe pain unresponsive to oral agents [2][6]
- Benzodiazepines: Widely recommended for muscle spasm, though no trial data support their use; anecdotal benefit reported [1]
- Antivenom (Antivenin Latrodectus mactans): Reserved for severe (Grade 3) cases refractory to supportive care, especially in children and elderly with comorbidities; not widely available in the US; allergic reaction risk up to 5%. An RCT of purified F(ab')2 antivenom demonstrated reduced treatment failures vs. placebo with no serious drug-related adverse events [1][10]
- Ineffective/not recommended: Calcium gluconate and magnesium — no demonstrated benefit [1][6]
- Antiemetics: For nausea/vomiting in Grade 2–3 [1]
4. Diet
- No specific dietary triggers or restrictions
- Hydration: Maintain adequate oral or IV hydration, particularly if vomiting or diaphoresis is significant
- NPO consideration if severe abdominal rigidity raises concern for surgical abdomen pending evaluation
5. Review of Systems
- Musculoskeletal: Muscle cramping, rigidity, fasciculations, back pain, extremity pain
- GI: Abdominal pain/rigidity, nausea, vomiting
- Cardiovascular: Chest pain, palpitations, dyspnea
- Neurologic: Headache, restlessness, anxiety, paresthesias
- Autonomic: Diaphoresis (pattern and distribution), salivation, lacrimation
- GU: Priapism (reported for most Latrodectus species), urinary retention [2]
- Dermatologic: Bite site appearance (solitary papule, target lesion, local erythema — no necrosis) [1][11]
6. Collateral History and Family History
- Collateral: Witnesses to the bite, spider identification (bring the spider if available), outdoor activity context, time of bite
- Pediatric cases: Caregiver history is critical — children may present with nonspecific irritability without witnessed bite [3][12]
- Allergy history: Prior spider bites, prior antivenom exposure, horse serum allergy (relevant if antivenom considered) [13]
- Family history is generally not contributory
7. Risk Factors
- Outdoor activity in warm weather months (peak in summer/early fall; exposures peak in September) [4-5]
- Occupational exposure: Agricultural workers, gardeners, military field exercises, construction workers [5][8]
- Geographic distribution: Found throughout the US (5 widow species); also expanding northward with climate change [4][12]
- Age extremes: Children and elderly at higher risk for severe envenomation [1][8]
- Comorbidities: Cardiovascular disease increases risk of complications [8-9]
- Sex: 58% of reported cases involve males [4]
8. Differential Diagnosis
- Acute abdomen/peritonitis: Severe abdominal rigidity from latrodectism can closely mimic surgical abdomen [1][5]
- Acute coronary syndrome/myocardial infarction: Chest pain with hypertension and tachycardia [1][7]
- Other envenomations: Scorpion sting (Centruroides), brown recluse bite (distinguished by necrotic wound, not muscle spasm) [11]
- Staphylococcus aureus skin infection: Many suspected spider bites are actually MRSA/MSSA abscesses [1]
- Tetanus: Muscle rigidity and autonomic instability
- Organophosphate poisoning: Cholinergic toxidrome with diaphoresis, salivation, muscle fasciculations
- Pheochromocytoma crisis: Hypertension, tachycardia, diaphoresis
- Serotonin syndrome: Muscle rigidity, autonomic instability, diaphoresis
9. Past Medical History
- Cardiovascular disease: Increases risk of cardiac complications (myocarditis, arrhythmia) [8-9]
- Prior envenomation: Previous Latrodectus bites or antivenom exposure (risk of hypersensitivity on re-exposure) [14]
- Atopic/allergy history: Relevant if antivenom is being considered
- Chronic pain conditions or opioid use: May affect analgesic management
- Tetanus immunization status [1]
10. Physical Exam
- Vital signs: Hypertension and tachycardia are hallmarks of Grade 3 envenomation [1][13]
- Bite site: Solitary papule, puncture, or "target lesion"; local erythema possible but no necrosis (distinguishes from brown recluse) [1][11]
- Musculoskeletal: Diffuse muscle rigidity — classically abdominal wall rigidity ("board-like abdomen") without true peritoneal signs (abdomen is rigid but non-tender to deep palpation, and bowel sounds are present)
- Skin: Diaphoresis — look for pathognomonic patterns: localized to bite site, bilateral below-knee, or asymmetric regional distribution [2]
- Face: Latrodectus facies — periorbital edema, lacrimation, blepharospasm (rare but distinctive) [3]
- Neurologic: Restlessness, muscle fasciculations, hyperreflexia
- Pediatric: Generalized erythema, inconsolable crying, drooling [1]
11. Lab Studies
- Diagnosis is clinical — no confirmatory lab test or venom assay exists [2]
- Generally not needed for mild (Grade 1) envenomation
- For Grade 2–3 or when complications are suspected:
- Troponin/CK-MB: If chest pain or suspected cardiac involvement [2][7][9]
- CK/myoglobin: If rhabdomyolysis suspected [5][9]
- BMP: Electrolytes, renal function (especially if rhabdomyolysis or significant fluid losses)
- CBC: Generally nonspecific; may show leukocytosis
- Urinalysis: Myoglobinuria if rhabdomyolysis
- Calcium and magnesium levels are not clinically useful for guiding treatment [1]
12. Imaging
- Routine imaging is not indicated
- Abdominal imaging (CT or X-ray) may be obtained if acute abdomen cannot be clinically distinguished from latrodectism — expect no surgical pathology
- Chest X-ray: Consider if respiratory distress or suspected pulmonary edema [8]
- Echocardiography: If myocarditis or Takotsubo cardiomyopathy suspected [7-8]
13. Special Tests
- Envenomation grading scaleAFP + 1[1][6]
- Poison Control consultation (1-800-222-1222) — recommended for all confirmed or suspected envenomations [4]
- No point-of-care venom detection test is available [2]
14. ECG
- Obtain ECG in Grade 3 envenomation or any patient with chest pain, dyspnea, or hemodynamic instability [2][7]
- Reported findings:
- ST-segment elevation (diffuse, without reciprocal changes — consistent with myocarditis rather than STEMI) [7]
- T-wave amplitude augmentation [7]
- Sinus tachycardia
- Arrhythmias (rare) [8]
- AV conduction disturbances [15]
- Some authors recommend ECG for all envenomated patients given the potential for fatal cardiac involvement [7]
15. Assessment
- Most bites do not result in systemic envenomation — the majority of cases are Grade 1 (65% minor effects) [1][4]
- Systemic envenomation (latrodectism) occurs in approximately one-third of cases and is characterized by the triad of painful muscle rigidity, diaphoresis, and autonomic disturbances [2][13]
- Symptoms are self-limited (48–72 hours) and rarely fatal in the US (no deaths reported in a 9-year NPDS review of 23,409 exposures) [1][4]
- Atypical presentations to recognize: acute abdomen mimic, ACS mimic, inconsolable child without witnessed bite [1][3]
- Complications: Myocarditis, rhabdomyolysis, Takotsubo cardiomyopathy, respiratory failure (rare) [5][8-9]
16. Treatment Plan
Initial stabilization:
- ABCs, IV access, cardiac monitoring for Grade 3
- Wound care with soap and water, cold packs [1]
- Tetanus prophylaxis if indicated [1]
Pharmacologic management by grade:
- Grade 1: Oral NSAIDs/acetaminophen [1]
- Grade 2: Add oral or parenteral opioids (e.g., IV morphine), oral or parenteral benzodiazepines (e.g., IV diazepam or lorazepam) for muscle spasm, antiemetics [1][6]
- Grade 3: Parenteral opioids + parenteral benzodiazepines; consider antivenom if refractory to supportive measures [1][6]
Antivenom considerations:
- Antivenom provides the most rapid symptom resolution (mean 31 minutes) and reduces hospitalization (12% vs. 52%) [6]
- An RCT of F(ab')2 antivenom showed significantly reduced treatment failures vs. placebo (52% vs. 77%) with no serious adverse events [10]
- Reserve for Grade 3 refractory to supportive care, especially in children, elderly, and patients with cardiovascular comorbidities [1]
- Risk of allergic reaction up to 5%; one reported fatality from bronchospasm after antivenom [1][6]
- Availability is limited in the US [1]
Do NOT use: Calcium gluconate or magnesium — ineffective [1][6]
17. Disposition
- Discharge (Grade 1): After observation period (4–6 hours), symptom improvement, normal vitals, adequate oral pain control
- Extended observation (Grade 2): Monitor for progression to Grade 3; discharge if symptoms controlled and stable
- Admission (Grade 3): Generalized symptoms, abnormal vital signs, refractory pain, need for parenteral medications, suspected cardiac involvement [1]
- ICU consideration: Hemodynamic instability, respiratory compromise, myocarditis, significant rhabdomyolysis
- Consult Poison Control for all cases; toxicology consultation for Grade 3 or antivenom consideration [4]
- Cardiology consultation if troponin elevation or ECG changes [7]
18. Follow Up / Return Precautions
- Follow-up: Primary care within 24–48 hours for Grade 2 patients discharged from ED; wound check as needed
- Expected course: Symptoms typically resolve within 48–72 hours; pain may wax and wane in waves [1]
- Return immediately for:
- Worsening or new-onset chest pain, shortness of breath
- Severe abdominal pain or rigidity
- Uncontrolled pain despite prescribed medications
- Fever, wound infection signs
- Weakness, dark urine (rhabdomyolysis)
- Pediatric patients: inconsolable crying, poor feeding, lethargy
- Patient counseling: Avoid outdoor areas where widows are common; wear gloves when handling woodpiles, yard debris, or stored equipment; shake out shoes and clothing left outdoors [1][5]
References
1. Arthropod Bites and Stings. — Herness J, Snyder MJ, Newman RS. American Family Physician. 2022.
2. Arthropod Bites and Stings. — Herness J, Snyder MJ, Newman RS. American Family Physician. 2022.
3. Arthropod Bites and Stings. — Herness J, Snyder MJ, Newman RS. American Family Physician. 2022.
4. Spider Bite. — Isbister GK, Fan HW. Lancet. 2011.
5. Spider Bite. — Isbister GK, Fan HW. Lancet. 2011.
6. Latrodectus Facies After Latrodectus Hesperus Envenomation In a Pediatric Patient. — Halmo LS, Hurst IA, Ng PC, Wang GS. The Journal of Emergency Medicine. 2019.
7. Latrodectus Facies After Latrodectus Hesperus Envenomation In a Pediatric Patient. — Halmo LS, Hurst IA, Ng PC, Wang GS. The Journal of Emergency Medicine. 2019.
8. A US Perspective of Symptomatic Latrodectus Spp. Envenomation and Treatment: A National Poison Data System Review. — Monte AA, Bucher-Bartelson B, Heard KJ. The Annals of Pharmacotherapy. 2011.
9. A US Perspective of Symptomatic Latrodectus Spp. Envenomation and Treatment: A National Poison Data System Review. — Monte AA, Bucher-Bartelson B, Heard KJ. The Annals of Pharmacotherapy. 2011.
10. Case Report: Soldier With Latrodectism After Black Widow Spider Bite During a Field Training Exercise. — Kubena BE, Umar MA, Walker JD, Harper H. Military Medicine. 2023.
11. Case Report: Soldier With Latrodectism After Black Widow Spider Bite During a Field Training Exercise. — Kubena BE, Umar MA, Walker JD, Harper H. Military Medicine. 2023.
12. Clinical Presentation and Treatment of Black Widow Spider Envenomation: A Review of 163 Cases. — Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Annals of Emergency Medicine. 1992.
13. Clinical Presentation and Treatment of Black Widow Spider Envenomation: A Review of 163 Cases. — Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Annals of Emergency Medicine. 1992.
14. Myocarditis After Black Widow Spider Envenomation. — Sari I, Zengin S, Davutoglu V, Yildirim C, Gunay N. The American Journal of Emergency Medicine. 2008.
15. Myocarditis After Black Widow Spider Envenomation. — Sari I, Zengin S, Davutoglu V, Yildirim C, Gunay N. The American Journal of Emergency Medicine. 2008.
16. Latrodectism in Europe (1973-2025): A Systematic Review of Clinical Manifestations, Management and Outcomes. — Terzi I, Delivalta N, Ntoga M, Stamatiou I. Toxicon : Official Journal of the International Society on Toxinology. 2026.
17. Latrodectism in Europe (1973-2025): A Systematic Review of Clinical Manifestations, Management and Outcomes. — Terzi I, Delivalta N, Ntoga M, Stamatiou I. Toxicon : Official Journal of the International Society on Toxinology. 2026.
18. Troponin Elevation After Black Widow Spider Envenomation. — Bush SP, Davy JV. Cjem. 2015.
19. Troponin Elevation After Black Widow Spider Envenomation. — Bush SP, Davy JV. Cjem. 2015.
20. The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab')2 Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. — Dart RC, Bush SP, Heard K, et al. Annals of Emergency Medicine. 2019.
21. The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab')2 Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. — Dart RC, Bush SP, Heard K, et al. Annals of Emergency Medicine. 2019.
22. 2024 American Heart Association and American Red Cross Guidelines for First Aid. — Hewett Brumberg EK, Douma MJ, Alibertis K, et al. Circulation. 2024.
23. 2024 American Heart Association and American Red Cross Guidelines for First Aid. — Hewett Brumberg EK, Douma MJ, Alibertis K, et al. Circulation. 2024.
24. A Case of Pediatric Northern Black Widow Spider (Latrodectus Variolus) Bite in New York, USA. — Rochlin I, Hockett W, Francis A. Toxicon : Official Journal of the International Society on Toxinology. 2021.
25. A Case of Pediatric Northern Black Widow Spider (Latrodectus Variolus) Bite in New York, USA. — Rochlin I, Hockett W, Francis A. Toxicon : Official Journal of the International Society on Toxinology. 2021.
26. Black Widow Spider (Latrodectus Mactans) Antivenom in Clinical Practice. — Monte AA. Current Pharmaceutical Biotechnology. 2012.
27. Black Widow Spider (Latrodectus Mactans) Antivenom in Clinical Practice. — Monte AA. Current Pharmaceutical Biotechnology. 2012.
28. Hypersensitivity vs. Uncommonly Severe Local Envenoming by the Red-Back Spider, Latrodectus Hasselti Thorell, 1870 (Araneae: Theridiidae). — Weinstein SA. Toxicon : Official Journal of the International Society on Toxinology. 2024.
29. Hypersensitivity vs. Uncommonly Severe Local Envenoming by the Red-Back Spider, Latrodectus Hasselti Thorell, 1870 (Araneae: Theridiidae). — Weinstein SA. Toxicon : Official Journal of the International Society on Toxinology. 2024.
30. Severe Spp. Envenomation: A Review of the Literature. — Chippaux JP, Amri K. Clinical Toxicology. 2021.
31. Severe Spp. Envenomation: A Review of the Literature. — Chippaux JP, Amri K. Clinical Toxicology. 2021.